Pricing
Login
Home
Charts
Search
Watchlist
Products

Mangalam Drugs and Organics Ltd

MANGALAM
₹27.55-3.54%20 Nov 2026
Reports
Pharma API

Mangalam Drugs and Organics Ltd

MANGALAM
₹27.55
-3.54%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹44Cr
Close
Close Price
₹27.55
Industry
Industry
Pharma API
PE
Price To Earnings
—
PS
Price To Sales
0.17
Revenue
Revenue
₹262Cr
Rev Gr TTM
Revenue Growth TTM
-2.26%
PAT Gr TTM
PAT Growth TTM
-92.47%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
9710277808973575058675779
Growth YoY
Revenue Growth YoY%
-8.9-28.8-25.3-38.0-34.2-7.5-0.260.3
Expenses
ExpensesCr
909168718063625260735681
Operating Profit
Operating ProfitCr
71289910-5-3-2-61-1
OPM
OPM%
7.211.410.710.99.913.6-8.1-5.7-2.6-8.31.6-1.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
344434454344
Depreciation
DepreciationCr
444445454544
PBT
PBTCr
041112-13-12-10-13-7-9
Tax
TaxCr
00-2-1021-5001-2
PAT
PATCr
143310-14-7-10-13-8-7
Growth YoY
PAT Growth YoY%
158.0-98.3-614.9-373.2-862.8-22,466.744.61.9
NPM
NPM%
0.53.53.53.41.40.1-24.1-14.8-16.9-19.9-13.4-9.1
EPS
EPS₹
0.32.21.71.70.80.0-8.7-4.6-6.2-8.5-4.8-4.5
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
9710277808973575058675779
Growth YoY
Revenue Growth YoY%
-8.9-28.8-25.3-38.0-34.2-7.5-0.260.3
Expenses
ExpensesCr
909168718063625260735681
Operating Profit
Operating ProfitCr
71289910-5-3-2-61-1
OPM
OPM%
7.211.410.710.99.913.6-8.1-5.7-2.6-8.31.6-1.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
344434454344
Depreciation
DepreciationCr
444445454544
PBT
PBTCr
041112-13-12-10-13-7-9
Tax
TaxCr
00-2-1021-5001-2
PAT
PATCr
143310-14-7-10-13-8-7
Growth YoY
PAT Growth YoY%
158.0-98.3-614.9-373.2-862.8-22,466.744.61.9
NPM
NPM%
0.53.53.53.41.40.1-24.1-14.8-16.9-19.9-13.4-9.1
EPS
EPS₹
0.32.21.71.70.80.0-8.7-4.6-6.2-8.5-4.8-4.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
369318232262
Growth
Revenue Growth%
-13.8-26.9-2.3
Expenses
ExpensesCr
351282247270
Operating Profit
Operating ProfitCr
1735-15-7
OPM
OPM%
4.711.1-6.4-2.8
Other Income
Other IncomeCr
0111
Interest Expense
Interest ExpenseCr
14151615
Depreciation
DepreciationCr
15171817
PBT
PBTCr
-115-49-39
Tax
TaxCr
-2-2-4-1
PAT
PATCr
-97-44-38
Growth
PAT Growth%
174.1-760.6-92.5
NPM
NPM%
-2.52.1-19.1-14.5
EPS
EPS₹
-5.74.3-28.1-24.1
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
369318232262
Growth
Revenue Growth%
-13.8-26.9-2.3
Expenses
ExpensesCr
351282247270
Operating Profit
Operating ProfitCr
1735-15-7
OPM
OPM%
4.711.1-6.4-2.8
Other Income
Other IncomeCr
0111
Interest Expense
Interest ExpenseCr
14151615
Depreciation
DepreciationCr
15171817
PBT
PBTCr
-115-49-39
Tax
TaxCr
-2-2-4-1
PAT
PATCr
-97-44-38
Growth
PAT Growth%
174.1-760.6-92.5
NPM
NPM%
-2.52.1-19.1-14.5
EPS
EPS₹
-5.74.3-28.1-24.1
Sales CAGR
1 Year-27%
3 Years-
5 Years-
TTM-2%
Avg. ROCE
1 Year-16%
3 Years-2%
5 Years-
TTM-14%
CFO / EBITDA
1 Year-
3 Years135%
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
16161616
Reserves
ReservesCr
1201338772
Current Liabilities
Current LiabilitiesCr
164192197198
Non Current Liabilities
Non Current LiabilitiesCr
34261512
Total Liabilities
Total LiabilitiesCr
334366315298
Current Assets
Current AssetsCr
176199156146
Non Current Assets
Non Current AssetsCr
158167159152
Total Assets
Total AssetsCr
334366315298
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
16161616
Reserves
ReservesCr
1201338772
Current Liabilities
Current LiabilitiesCr
164192197198
Non Current Liabilities
Non Current LiabilitiesCr
34261512
Total Liabilities
Total LiabilitiesCr
334366315298
Current Assets
Current AssetsCr
176199156146
Non Current Assets
Non Current AssetsCr
158167159152
Total Assets
Total AssetsCr
334366315298

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4434
Investing Cash Flow
Investing Cash FlowCr
-12-19-12
Financing Cash Flow
Financing Cash FlowCr
5-226
Net Cash Flow
Net Cash FlowCr
-31-2
Free Cash Flow
Free Cash FlowCr
-823-8
CFO To PAT
CFO To PAT%
-43.1633.8-9.4
CFO To EBITDA
CFO To EBITDA%
22.5121.1-28.0
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4434
Investing Cash Flow
Investing Cash FlowCr
-12-19-12
Financing Cash Flow
Financing Cash FlowCr
5-226
Net Cash Flow
Net Cash FlowCr
-31-2
Free Cash Flow
Free Cash FlowCr
-823-8
CFO To PAT
CFO To PAT%
-43.1633.8-9.4
CFO To EBITDA
CFO To EBITDA%
22.5121.1-28.0

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1471174444
Price To Earnings
Price To Earnings
17.5
Price To Sales
Price To Sales
0.40.40.20.2
Price To Book
Price To Book
1.10.80.50.5
EV To EBITDA
EV To EBITDA
14.05.8-10.0-18.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.333.721.321.3
OPM
OPM%
4.711.1-6.4-2.8
NPM
NPM%
-2.52.1-19.1-14.5
ROCE
ROCE%
1.28.3-15.5-13.7
ROE
ROE%
-6.74.5-43.1-43.3
ROA
ROA%
-2.71.8-14.1-12.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1471174444
Price To Earnings
Price To Earnings
17.5
Price To Sales
Price To Sales
0.40.40.20.2
Price To Book
Price To Book
1.10.80.50.5
EV To EBITDA
EV To EBITDA
14.05.8-10.0-18.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.333.721.321.3
OPM
OPM%
4.711.1-6.4-2.8
NPM
NPM%
-2.52.1-19.1-14.5
ROCE
ROCE%
1.28.3-15.5-13.7
ROE
ROE%
-6.74.5-43.1-43.3
ROA
ROA%
-2.71.8-14.1-12.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2571911634437205
Close PriceClose₹58.679.8130.4627.55117.954.01302.00
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE6.7821.609.64
Price To SalesPS0.65109.520.280.171.246.07
RevenueRevenueCr3952583262303
Revenue Growth TTMRev Gr TTM%-70.8%42.4%-2.3%-8.0%-96.5%
PAT Growth TTMPAT Gr TTM%81.7%35.8%-92.5%-14.1%66.5%
Market CapitalizationMkt CapCr2571911634437205
Close PriceClose₹58.679.8130.4627.55117.954.01302.00
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE6.7821.609.64
Price To SalesPS0.65109.520.280.171.246.07
RevenueRevenueCr3952583262303
Revenue Growth TTMRev Gr TTM%-70.8%42.4%-2.3%-8.0%-96.5%
PAT Growth TTMPAT Gr TTM%81.7%35.8%-92.5%-14.1%66.5%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews